AbbVie (ABBV) maintains long-term guidance for high single-digit revenue growth through the decade, with EPS growth outpacing sales via operating-margin expansion, via JPM Conference

AbbVie is reaffirming its long-term revenue growth expectations, targeting high single-digit increases over the next decade.

Newsquawk StaffPublished On the live feed at 8 more headlines followed before this page went public
Newsquawk headlinesUTC

US sells 17-week bills at a high rate of 3.560%, B/C 3.00x

European Closes: Euro Stoxx 50 -0.36% at 6,008, Dax 40 -0.53% at 25,286, FTSE 100 +0.46% at 10,184, CAC 40 -0.19% at 8,331, FTSE MIB +0.27% at 45,647, IBEX 35 +0.05% at 17,696, PSI +0.10% at 8,568, SMI +0.61% at 13,446, AEX -0.04% at 997.

AbbVie (ABBV) maintains long-term guidance for high single-digit revenue growth through the decade, with EPS growth outpacing sales via operating-margin expansion, via JPM Conference

Citi (C) CEO warns of more job cuts and calls time on ‘old, bad habits’, Bloomberg reports; CFO expects NII ex markets to be up between 5-6% in 2026

BoE Deputy Governor Ramsden says removing ring-fencing of banks would be a real challenge to UK financial stability framework

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

With projected EPS growth outpacing revenue through margin improvements, this guidance indicates confidence in operational efficiency that could help support the stock's performance amidst competitive pressures in the biotechnology sector.

Related headlines

The whole workspace, free to try.

Try it free